BioRestorative Therapies, Inc. Stock price Other OTC
Equities
BRTX
US0906554086
Biotechnology & Medical Research
Financials (USD)
Sales 2023 * | 142K | Sales 2024 * | 60K | Capitalization | 9.13M |
---|---|---|---|---|---|
Net income 2023 * | -14M | Net income 2024 * | -17M | EV / Sales 2023 * | 64.3 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 152 x |
P/E ratio 2023 * |
-0.4
x | P/E ratio 2024 * |
-0.64
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.53% |
Managers | Title | Age | Since |
---|---|---|---|
Lance Alstodt
CEO | Chief Executive Officer | 53 | 18-09-30 |
Robert Kristal
DFI | Director of Finance/CFO | - | 21-11-03 |
Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Williams
BRD | Director/Board Member | 51 | 21-10-28 |
David Rosa
BRD | Director/Board Member | 59 | 21-10-28 |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 11-04-12 |
1st Jan change | Capi. | |
---|---|---|
+2.24% | 108B | |
+10.32% | 104B | |
+6.61% | 23.66B | |
-11.87% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-13.33% | 16.19B | |
+3.61% | 13.72B | |
+35.21% | 12.22B |